Robert Wicke Appointed as New CEO of Halo Labs

Wednesday, August 1, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, Aug. 1, 2018 /PRNewswire/ -- Halo Labs, a venture-backed scientific instrumentation company developing

high-throughput biopharmaceutical quality control tools, today announced the appointment of Robert Wicke as Chief Executive Officer.

Robert is a seasoned executive with over 25 years of experience growing successful

life science instrumentation companies through the commercialization of innovative new products and inorganic growth. Prior to joining Halo Labs, he held various senior leadership positions including General Manager at Pall ForteBio, Senior VP of Instrumentation R&D at Pall, VP of Product Development at Molecular Devices, and VP of Software Engineering at Axon Instruments.

"We are thrilled to have someone with Robert's successful and extensive background in bringing life science products to market join Halo Labs. His passion for developing high-quality scientific tools that target critical customer problems aligns perfectly with our company vision," said Dr. Bernardo Cordovez, Founder and Chief Scientific Officer. "We look forward to Robert's proven track record of growth taking us to the next level."

"I am very excited and honored to join Halo Labs as they expand both their product portfolio and reach in the biopharmaceutical tools space," said Robert Wicke. "We have a fantastic team and a great product in the HORIZON. I am eager to start building on the existing success of the company."

Robert Wicke succeeds Dr. Robert Hart who is transitioning to Chief Technology Officer where he will focus on innovative new products.  

About Halo Labs Halo Labs commercializes biopharmaceutical analysis instrumentation. The company was named Philadelphia Life Science Startup of 2012. Halo Labs is venture backed by BioAdvance, BroadOak Capital Partners and the Ben Franklin Technology Partners. Halo Labs' flagship product, the HORIZONŪ, enables for the first time high throughput - low volume subvisible particle analysis and is funded by prestigious small business grants from NIST and the FDA. For more information, please visit www.halolabs.com

 

Cision View original content:http://www.prnewswire.com/news-releases/robert-wicke-appointed-as-new-ceo-of-halo-labs-300689749.html

SOURCE Halo Labs



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store